OpenAlex
PricingAboutJobs
Log inGet started
Author

Erica Goff

Institution: University of Alabama at Birmingham
Observed institutions: Biogen (United States), Greenwich Hospital, Ascension, Baylor College of Medicine, Sigma Theta Tau International, Novant Health, University of Alabama at Birmingham, Routledge (United Kingdom), Rocky Mountain Multiple Sclerosis Clinic, Novant Health Presbyterian Medical Center, Dallas VA Medical Center, Biogen (Switzerland)
ORCID: 0000-0003-0250-415X
Observed ORCID: 0000-0003-0250-415X
OpenAlex ID: A5113038906
Practical Clinical Guidelines for Natalizumab Treatment in Patients With Relapsing Multiple Sclerosis
2023 · Shirley O'Leary, Helen T. Brugger, et al. · Journal of Infusion Nursing · 5
Comparative Effectiveness and Risk of Severe Infection in Adult Patients With MS Treated With Diroximel Fumarate Versus Anti-CD20 Monoclonal Antibodies: A Real-World Claims Analysis
2026 · Ahmed Z. Obeidat, Michelle Betz, et al. · Advances in Therapy · 1
PDF
Efficacité comparative et risques d’infection sévère (IS) chez les patients adultes atteints de sclérose en plaques (PwMS) traités par diroximel fumarate (DRF) ou anticorps monoclonaux anti-CD20 : analyse de données de soins/remboursements en vie réelle
2025 · Ahmed Z. Obeidat, Michelle Betz, et al. · Revue Neurologique
Works count: 3
Citation count: 6
H-index: 1
I10-index:
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security